Urodynamic effects of oral oxybutynin chloride in children with myelomeningocele and detrusor hyperreflexia

Urology

Volumn 51, Issue 1, 1998, Pages 94-98

  Goessl, C ^a   Knispel, H H ^a   Fiedler, U ^a   Harle B ^a   Steffen Wilke, K ^a   Miller, K ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OXYBUTYNIN;

ADOLESCENT; ARTICLE; BLADDER CAPACITY; CHILD; CLINICAL ARTICLE; DETRUSOR DYSSYNERGIA; DETRUSOR MUSCLE; DRUG EFFICACY; DRUG SAFETY; FATIGUE; FEMALE; FLUSHING; HUMAN; INFANT; INTERMITTENT CATHETERIZATION; MALE; MENINGOMYELOCELE; PRIORITY JOURNAL; URINE INCONTINENCE; URODYNAMICS; XEROSTOMIA;

ADMINISTRATION, ORAL; ADOLESCENT; CHILD; CHILD, PRESCHOOL; CHOLINERGIC ANTAGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; MALE; MANDELIC ACIDS; MENINGOMYELOCELE; REFLEX, ABNORMAL; URINARY BLADDER; URODYNAMICS;

EID: 0031952242     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00489-5     Document Type: Article

References (27)

1. Bauer SB, Hallett M, Khoshbin S, Lebowitz RL, Winston KR, Gibson S, Colodny AH, and Retik AB: Predictive value of urodynamic evaluation in newborns with myelodysplasia. JAMA 252: 650-652, 1994.
2. Galloway NTM, Mekras JA, Helms M, and Webster GD: An objective score to predict upper tract deterioration in myelodysplasia. J Urol 145: 535-537, 1991.
3. McGuire EJ, Woodside JR, Borden TA, and Weiss RM: Prognostic value of urodynamic testing in myelodysplastic patients. J Urol 126: 205-209, 1981.
4. Steinhardt GF, Goodgold HM, and Samuels LD: The effect of intravesical pressure on glomerular filtration rate in patients with myelomeningocele. J Urol 140(5 Pt 2): 1293-1295, 1988.
5. Diokno AC, Kass E, and Lapides J: New approach to myelodysplasia. J Urol 116: 771-772, 1976.
6. Geraniotis E, Koff SA, and Enrile B: The prophylactic use of clean intermittent catheterization in the treatment of infants and young children with myelomeningocele and neurogenic bladder dysfunction. J Urol 139: 85-86, 1988.
7. Hilwa N, and Perlmutter AD: The role of adjunctive drug therapy for intermittent catheterization and self-catheterization in children with vesical dysfunction. J Urol 119: 551-554, 1978.
8. Kasabian NG, Bauer SB, Dyro FM, Colodny AC, Mandell J, and Retik AB: The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration. Am J Dis Child 146: 840-843, 1992.
9. Lish PM, Labudde JA, Peters EL, and Robbins SI: Oxybutynin - a musculotropic antispasmodic drug with moderate anticholinergic action. Arch Int Pharmacodyn 156: 467-488, 1965.
10. Diokno AC, and Lapides J: Oxybutynin: a new drug with analgesic and anticholinergic properties. J Urol 108: 307-309, 1972.
11. Thüroff JW, Bunke B, Ebner A, Faber P, de Geeter P, Hannappel J, Heidler H, Madersbacher H, Melchior H, Schäfer W, et al: Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo. J Urol 145: 813-817, 1991.
12. Buyse G, Verpoorten C, Vereecken R, and Casaer P: Treatment of neurogenic bladder dysfunction in infants and children with neurospinal dysraphism with clean intermittent (self) catheterization and optimized intravesical oxybutynin hydrochloride therapy. Eur J Pediatr Surg 5(suppl): 31-34, 1995.
13. Kaplinski R, Greenfield S, Wan J, and Fera M: Expanded followup of intravesical oxybutynin chloride use in children with neurogenic bladder. J Urol 156: 753-756, 1996.
14. Painter KA, Vates TS, Bukowski TP, Fleming P, Freedman AL, Smith CA, Gonzalez R, and Perlmutter AD: Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia. J Urol 156: 1459-1462, 1996.
15. Kasabian NG, Vlachiotis JD, Lais A, Klumpp B, Kelly MD, Siroky MB, and Bauer SB: The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia. J Urol 151: 944-945, 1994.
16. Hehir M, and Fitzpatrick JM: Oxybutinin and the pre-vention of urinary incontinence in spina bifida. Eur Urol 11: 254-256, 1985.
17. Abrams P, Freeman RN, Anderström C, and Mattiasson A: Efficacy and tolerability of tolterodine vs. oxybutynin and placebo in patients with detrusor instability (abstract). J Urol 157 (suppl): 103, 1997.
18. The International Continence Society, February, 1975: First report on the standardisation of terminology of lower urinary tract function. Br J Urol 48: 39-42, 1976.
19. Hernandez RD, Hurwitz RS, Foote JE, Zimmern PE, and Leach GE: Nonsurgical management of threatened upper urinary tracts and incontinence in children with myelomeningocele. J Urol 152(5 Pt 2): 1582-1585, 1994.
20. Connor JP, Betrus G, Fleming P, Perlmutter AD, and Reitelmann C: Early cystometrograms can predict the response to intravesical instillation of oxybutynin chloride in myelomeningocele patients. J Urol 151: 1045-1047, 1994.
21. Palmer LS, Zebold K, Firlit CF, and Kaplan WE: Complications of intravesical oxybutynin chloride therapy in the pediatric myelomeningocele population. J Urol 157: 638-640, 1997.
22. Perez LM, Khoury J, and Webster GD: The value of urodynamic studies in infants less than 1 year old with congenital spinal dysraphism. J Urol 148(2 Pt 2): 584-587, 1992.
23. Purcell MH, and Gregory JG: Intermittent catheterization: evaluation of complete dryness and independence in children with myelomeningocele. J Urol 132: 518-520, 1984.
24. Mulcahy JJ, James HE, and McRoberts W: Oxybutynin chloride combined with intermittent clean catheterization in the treatment of myelomeningocele patients. J Urol 118: 95-96, 1977.
25. Massad CA, Kogan BA, and Trigo-Rocha FE: The pharmacokinetics of intravesical and oral oxybutynin chloride. J Urol 148(2 Pt 2): 595-597, 1992.
26. Jonville AP, Dutertre JP, Barbellion M, and Autret E: Effets indésirables du chlorure d'oxybutynine (Ditropan®) en pediatric. Arch Fr Pediatr 50: 27-29, 1993.
27. Greenfield SP, and Fera M: The use of intravesical oxybutynin chloride in children with neurogenic bladder. J Urol 146(2 Pt 2): 532-534, 1991.